Illuminavs.Revvity
ILMN vs RVTY · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Illumina is about 2.3× larger than Revvity by market cap; Illumina trades at the lower P/E (33.7 vs 52.6); year to date, Illumina leads (+45.0% vs +16.1%).
Side by side
| ILMN | RVTY | |
|---|---|---|
| Market cap | $28.8B | $12.6B |
| Price | $190.20 | $112.29 |
| Today | −1.8% | −0.6% |
| Return YTD | +45.0% | +16.1% |
| Return 1Y | +90.1% | +9.7% |
| P/E | 33.7 | 52.6 |
| P/S | 6.6 | 4.3 |
| P/B | 10.8 | 1.8 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
IlluminaILMN
American leader in DNA sequencing — instruments and consumables used in research and clinical genomics.
Full ILMN profile →RevvityRVTY
Life science tools and diagnostics across newborn screening and research.
Full RVTY profile →More comparisons in Life science tools
See where ILMN and RVTY sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →